2016-2020 US POC/Point-of-Care Diagnostic Testing Market: Supplier Shares, Country Volume and Sales Segment Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review, Competitive Strategies
This new 1,172-page report from VPGMarketResearch contains 256 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patientMarket Segmentation Analysis Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:-Home/Personal Testing - Physician Offices/Group PracticesEmergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth CentersAnd by test category: - Routine and Special Chemistry Microbiology/Infectious Diseases Hematology Flow Cytometry Coagulation Immunoproteins Drgs of Abuse TDM Endocrine Function Tumor Markers Sales and Market Share AnalysisSales and market shares of major reagent and instrument suppliers
Current and Emerging Products
Analysis of over 130 diagnostic procedures. Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices
Technology Review
Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Competitive Assessments
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D
Strategic Recommendations
Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks
MethodologyThis report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearchs proprietary data files.Contains 1,172 pages and 256 tables
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patientMarket Segmentation Analysis Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:-Home/Personal Testing - Physician Offices/Group Practices
Current and Emerging Products
Analysis of over 130 diagnostic procedures. Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices
Technology Review
Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Competitive Assessments
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D
Strategic Recommendations
Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks
MethodologyThis report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearchs proprietary data files.Contains 1,172 pages and 256 tables
INTRODUCTION
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
MAJOR ROUTINE AND SPECIAL HEMATOLOGY TESTS
1. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
INSTRUMENTATION: Hematology Analyzers Manufactured by:
Abbott
Becton Dickinson
Beckman Coulter/Danaher
Biocode
Drew-Scientific
Diesse Ves Matic
Horiba
Menarini
Nihon Kohden
Polymedco
Sysmex
CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS A. MARKET SUMMARY
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
1. MAJOR SUPPLIERS’ INSTRUMENT PLACEMENTS, INSTALLED BASE, INSTRUMENT AND CONSUMABLES SALES, AND MARKET SHARES
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
MAJOR ROUTINE AND SPECIAL HEMATOLOGY TESTS
1. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
INSTRUMENTATION: Hematology Analyzers Manufactured by:
Abbott
Becton Dickinson
Beckman Coulter/Danaher
Biocode
Drew-Scientific
Diesse Ves Matic
Horiba
Menarini
Nihon Kohden
Polymedco
Sysmex
CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS A. MARKET SUMMARY
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
1. MAJOR SUPPLIERS’ INSTRUMENT PLACEMENTS, INSTALLED BASE, INSTRUMENT AND CONSUMABLES SALES, AND MARKET SHARES
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
LIST OF TABLES
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Hematology Consumable Market Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
U.S.A., Nursing Homes Hematology Reagent Market Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine Hematology Test Volume Forecast
U.S.A., Birth Centers Hematology Reagent Market Forecast
U.S.A., Hematology Analyzers Estimated Placements and Installed Base
U.S.A., Flow Cytometers Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Hematology Consumable Market Forecast
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
U.S.A., Nursing Homes Hematology Reagent Market Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine Hematology Test Volume Forecast
U.S.A., Birth Centers Hematology Reagent Market Forecast
U.S.A., Hematology Analyzers Estimated Placements and Installed Base
U.S.A., Flow Cytometers Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
